BriaCell: An Emerging Immuno-Oncology Company By: TalkMarkets August 14, 2023 at 12:24 PM EDT BriaCell has recently announced agreement with the FDA for their pivotal, registration trial in advanced metastatic breast cancer. Read More >> Related Stocks: Briacell Therapeutics Corp
